Literature DB >> 12716349

Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment.

E G M Couturier1, M A M Bomhof, A Knuistingh Neven, N P van Duijn.   

Abstract

We assessed the prevalence of menstrual migraine and its restrictions on daily activities in a representative Dutch population sample of 1181 Dutch women, aged 13-55 years. Further, we evaluated the potential role of oral contraceptives, and how menstrual migraine is treated. More than half suffered from menstrual complaints, a substantial proportion reported headache or migraine as a frequent problem. Use of oral contraceptives seemed to reduce the occurrence of menstrual complaints, but not the occurrence of headache and migraine. In our study, the prevalence of menstrual migraine (3%) is lower than in the literature, most probably because we did not use a selected group of patients but a population-based sample of ordinary women. It was confirmed that attacks of menstrual migraine are more severe, of longer duration, and more resistant to treatment than migraine attacks at other times of the month.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12716349     DOI: 10.1046/j.1468-2982.2003.00516.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  48 in total

1.  Sex matters: evaluating sex and gender in migraine and headache research.

Authors:  B Lee Peterlin; Saurabh Gupta; Thomas N Ward; Anne Macgregor
Journal:  Headache       Date:  2011-06       Impact factor: 5.887

2.  Menstrual migraine: update on pathophysiology and approach to therapy and management.

Authors:  Anne H Calhoun
Journal:  Curr Treat Options Neurol       Date:  2012-02       Impact factor: 3.598

Review 3.  Treatment of perimenstrual migraine with triptans: an update.

Authors:  Barbara Casolla; Luana Lionetto; Serena Candela; Lidia D'Alonzo; Andrea Negro; Maurizio Simmaco; Paolo Martelletti
Journal:  Curr Pain Headache Rep       Date:  2012-10

4.  Menstrual migraine: therapeutic approaches.

Authors:  E Anne Macgregor
Journal:  Ther Adv Neurol Disord       Date:  2009-09       Impact factor: 6.570

Review 5.  Menstrual migraine: what it is and does it matter?

Authors:  Letizia Maria Cupini; Ilenia Corbelli; Paola Sarchelli
Journal:  J Neurol       Date:  2020-01-28       Impact factor: 4.849

Review 6.  Treating migraine with contraceptives.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Fabiola Bergandi; Chiara Benedetto
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

Review 7.  Menstrual migraine.

Authors:  Ana Recober; Lynne O Geweke
Journal:  Curr Neurol Neurosci Rep       Date:  2005-03       Impact factor: 5.081

Review 8.  Estrogen, migraine, and vascular risk.

Authors:  Gianni Allais; Giulia Chiarle; Silvia Sinigaglia; Gisella Airola; Paola Schiapparelli; Chiara Benedetto
Journal:  Neurol Sci       Date:  2018-06       Impact factor: 3.307

Review 9.  Genetics of menstrual migraine: the epidemiological evidence.

Authors:  Michael Bjørn Russell
Journal:  Curr Pain Headache Rep       Date:  2010-10

10.  Optimizing prophylactic treatment of migraine: Subtypes and patient matching.

Authors:  Michel Dib
Journal:  Ther Clin Risk Manag       Date:  2008-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.